Sensorineural hearing loss (SNHL) is one of the most common sensory defects in humans. Hair cells are vulnerable to various ototoxic insults. Effective prevention of hair cell loss remains an unmet medical need. Apoptotic hair cell death, which involves active regulation of transcription, accounts for the majority of aminoglycoside-induced hair cells loss. As one of the important epigenetic covalent modifications, histone methylation is involved in the regulation of gene expression, development and reaction to injury. In particular, H3K9 dimethylation (H3K9me2) is critical for euchromatin gene silencing. In the present study, we examined the roles of two highly homologous histone methyltransfereases responsible for this modification, G9a/G9a-like protein (GLP), in the reaction to aminoglycoside-induced hair cell damage. We observed a rapid increase of H3K9me2 upon hair cell damage in organotypic cochlear cultures. Treatment with the G9a/GLP-specific inhibitors, BIX01294 or UNC0638, reduced the level of H3K9me2 and prevented hair cells from death. Local delivery of BIX01294 also prevented neomycin-induced in vivo auditory hair cell loss in the organ of Corti in a mouse damage model. It is unlikely that BIX01294 functions through blocking aminoglycoside absorption as it does not interfere with aminoglycoside uptaking by hair cells in the organotypic cochlear cultures. Our data revealed a novel role of histone methylation in otoprotection, which is of potential therapeutic value for SNHL management. As one of the most common sensory defects in humans, sensorineural hearing loss (SNHL) occurs in 450% of individuals between 50 and 80 years of age and affects 430,000 children annually, 1 largely due to the vulnerability of the sensory hair cells. The leading cause of SNHL is permanent inner ear hair cell damage; as mammalian hair cells are incapable of spontaneous self-regeneration.
As one of the most common sensory defects in humans, sensorineural hearing loss (SNHL) occurs in 450% of individuals between 50 and 80 years of age and affects 430,000 children annually, 1 largely due to the vulnerability of the sensory hair cells. The leading cause of SNHL is permanent inner ear hair cell damage; as mammalian hair cells are incapable of spontaneous self-regeneration. 2 Potential remedies to SNHL thus include protection from hair cell apoptosis and induced hair cell regeneration. 3, 4 However, effective regeneration of functional hair cells remains scientifically challenging. Therefore, active protection of cochlear hair cells is of critical importance for SNHL management.
Discordant disease susceptibilities have been shown in monozygotic twins despite their shared genetic background. The underlying molecular mechanism is believed to involve epigenetic modifications of the genome, characterised by dynamic changes in DNA methylation and noncoding RNAs, as well as diverse patterns of covalent histone modifications. 5 Recently, certain microRNAs were found to be associated with the onset and progression of deafness in the diminuendo mouse model, which showed progressive hearing loss starting from an early age, 6 indicating a role of epigenetic regulation in hearing biology.
Epigenetic modifications have an important role in the regulation of many chromosomal functions and are closely linked to certain biological events, such as transcriptional regulation, cell survival, differentiation, and cell death. [7] [8] [9] [10] Dimethylation of lysine 9 of histone H3 (H3K9me2) is a dynamic histone methylation mark associated with euchromatin gene silencing. Change of H3K9me2 is implicated in both embryogenesis and carcinogenesis. [11] [12] [13] With the development of potent and selective G9a and G9a-like protein (GLP) inhibitors, such as BIX01294 and UNC0638, 14, 15 it is possible to probe the G9a/GLP-mediated functions of H3K9me2 in detail through pharmacological inhibition. 14, 16 Notably, inhibition of G9a by the administration of BIX01294 led to the suppression of cell migration and invasion in certain types of infinitely proliferous cancer cells. 17, 18 However, the involvement of histone methylation in the fate determination of mammalian hair cells and the effects of H3K9me2 in terminally differentiated hair cells are still poorly understood.
In the present study, we analysed the involvement of H3K9me2 in the susceptibility of hair cells to injury. Our data showed that H3K9me2 rapidly increased following hair cell damage induced by aminoglycosides and preceded the death of the hair cells. Inhibition of G9a/GLP protected the auditory hair cells from death in neonatal organ of Corti explants in vitro. Pre-conditioning with BIX01294 also prevented hair cell loss induced by neomycin in vivo and improved hearing threshold. Suppression of H3K9me2 induced by ototoxic drugs may provide an effective way of clinical importance to protect hair cells from injury.
Results
Aminoglycoside induced a rapid increase of H3K9me2 in hair cell-injury models. Histone methylation has important roles in transcription regulation, genome integrity, and epigenetic inheritance. We first examined the pattern of H3K9me2 in normal cochlear epithelium using immunohistochemistry. H3K9me2 staining showed a punctate distribution in virtually all the hair cells, with the strongest signal observed at the edge of outer hair cells and a downward gradient leading to dramatically decreased staining in the inner hair cells (Figure 1a ).
We next examined H3K9me2 level in the cochlear epithelium upon damage in a neonatal neomycin-induced ototoxicity model. The global level of H3K9me2 was measured following neomycin incubation of different durations. We observed a significant increase of H3K9me2 staining in the organ of Corti without apparent hair cell loss after 15 min of incubation with 1 mM neomycin (Figure 1b) . This elevated level of H3K9me2 remained in the organ of Corti up to 3h after treatment (Figure 1c ), but disappeared after 24 h of treatment, largely due to the loss of hair cells that followed (data not shown). Figure 1 The global H3K9me2 levels increased rapidly upon hair cell damage. (a) H3K9me2 immunofluorescence was detected as punctuate staining in normal hair cells cultured as organ culture in serum-free medium. (b and c) The relative fluorescent intensity of H3K9me2 increased significantly after the addition of 1 mM neomycin for 15 min or 3 h when compared with the untreated group. (d) The H3K9me2 level increased after all of the following treatments: 100 mM cisplatin treatment for 3 h, 50 mM copper (CU) treatment for 3 h, ultraviolet (UV) irradiation for 15 min, or 1 mM neomycin treatment for 3 h, as confirmed by western blot analysis (n ¼ 12 per group in each trial) and quantified by the grey-degree numerical value in the form of mean ± S.E. values obtained from three replicates. Shown in the images is the middle turn segment. The red spots represent the H3K9me2 signal, the green fluorescence shows staining of the hair cells and the nuclei are labelled with 4,6-diamidino-2-phenylindole (DAPI). Bar ¼ 10 mm. **Po0.01. DDP; cisplatin; CON, control group
We next examined the H3K9me2 modification in three other hair cell injury models: cochlear epithelial cells were treated with 100 mM cisplatin for 3 h, with 50 mM copper for 3 h, or with ultraviolet rays for 15 min, using the 3-h treatment of 1 mM neomycin as a positive control. Western blot analysis confirmed the increase of H3K9me2 in the organ of Corti following all four types of damage (Figure 1d ).
Pharmacological inhibition of G9a/GLP by BIX01294 leads to decreased H3K9me2 in cochlear epithelium. BIX01294 is a selective inhibitor of G9a/GLP, two major euchromatin histone methyltransferases responsible for H3K9me2. We examined the H3K9me2 level following BIX01294 treatment using immunofluorescence staining. The H3K9me2 level in hair cells decreased significantly after 24 h of incubation with 2 mM BIX01294 when compared with the untreated group (Figures 2a-c) . Moreover, a dose-dependent effect was observed with varying BIX01294 concentrations (0, 2, and 10 mM) as determined by semi-quantitative western blot analysis, using total histone H3 as the loading control (Figure 2d ). Obvious loss of hair cells was not observed in the low-concentration (2 mM) BIX01294 treatment group, but hair cell loss was found at the high concentration (10 mM) to a mild extent (Figure 2c ). Therefore, we chose a concentration of 2 mM BIX01294 for further analysis.
Inhibition of G9a/GLP renders hair cells resistant to loss induced by neomycin. As the H3K9me2 modification increased rapidly upon neomycin-induced hair cell damage preceding cell death, we hypothesised that such epigenetic modulation may contribute to the onset of active apoptosis of the hair cells. We thus investigated whether suppression of H3K9me2 by BIX01294 could protect hair cells from aminoglycoside -induced hair cell loss. Four groups of experiments were conducted with the organ of Corti: 24 h 2 mM BIX01294 pre-treatment before neomycin treatment for 4 h; co-treatment of 2 mM BIX01294 and neomycin for 4 h; Supplementary  Table S1 . Significantly, more surviving hair cells and less apoptotic bodies were found in the pre-treatment group than the other three groups in the middle and basal segments (ANOVA and SNK-q test, P-value o0.01; Figures 3a-l) . The number of surviving hair cells in the pre-treatment group was also significantly higher than in the neomycin-only controls (ANOVA and SNK-q test, P-value o0.01; Figure 3m ), whereas that in the post-treatment group it was significantly lower than neomycin-only controls (ANOVA and SNK-q test, P-valueo0.01). Apparent hair cell loss was not found in the apical segment of the organ of Corti in any of the four groups.
To exclude the possibility of BIX01294 off-target effect, we treated the cultured organs of Corti with another selective and potent G9a/GLP inhibitor UNC0638. 15 Similar otoprotection was observed in the UNC0638 pre-treatment group (Figure 4 ), confirming that the otoprotection of BIX01294 and UNC0638 likely executes through G9a/GLP inhibition before aminoglycoside treatment.
To further investigate whether the otoprotective effect of BIX01294 can be extended to other hair cell-loss models, we examined it in cisplatin-induced hair cell-injury model. Explant culture of organ of Corti were pre-treated with 2 m BIX01294 then challenged with cisplatin for 4 h or directly challenged with cisplatin for 4 h as the control. The mean number of surviving hair cells and apoptotic bodies across various segments of the organ of Corti are counted and shown in Figure 5 . We observed significant otoprotection effect of BIX01294 (ANOVA and SNK-q test, P-value o0.01) in cisplatin-induced hair cell-loss model.
BIX01294 does not interfere with the uptake of aminoglycosides or hair cell function. We next investigated whether BIX01294 interferes with aminoglycoside uptake by monitoring the uptake of gentamicin tagged with Texas Red (GTTR) or the uptake of a membrane permeable probe FM1-43FX. GTTR efficiently entered hair cells in the cultured organs of Corti after 30 min of incubation at 37 1C both in the control group ( Figure 6a ) and in the BIX01294 pre-treatment group (Figure 6b ). Hair cells treated with or without BIX01294 were both able to effectively uptake FM1-43FX (Figures 6c and d ). These data indicated that BIX02194 does not interfere with aminoglycoside uptake in hair cells.
BIX01294 treatment prevents the apoptotic process induced by aminoglycosides. To assess whether the resistance to neomycin injury by BIX01294 pre-treatment is achieved through the inhibition of apoptosis induced by aminoglycosides, we investigated the mitochondrial function by examining the distribution of tetramethylrhodamine methyl ester (TMRM), a fluorescent lipophilic cation, in cochlear epithelium with or without BIX01294 pre-treatment. We found Figure 3 Assessment of hair cell survival and apoptosis upon neomycin treatment with or without BIX01294. (a-l) Organs of Corti were cultured in serum-free medium. They were either treated with neomycin alone (Neo), neomycin with BIX01294 pre-treatment (BIX-Neo), neomycin and BIX01294 co-treatment (co-treatment), or neomycin with BIX01294 post treatment (Neo-BIX). Shown here are the confocal images of the apical, middle, and basal turns from these four groups, respectively. The hair cells were labelled with Math1-GFP (Math1-green fluorescent protein; green), and the nuclei were DAPI (4,6-diamidino-2-phenylindole) stained (blue). Arrows in f, h, i, k, and l indicate the apoptotic bodies with condensed or fragmented nuclei. Bar ¼ 5 mm. (m) Quantitative analysis of hair cell protection by BIX01294. The samples were divided into six segments of equal length, which was called segment 1, 2, 3, 4, 5, and 6 from apex to base. We counted the number of hair cells in each visual field with the same length of each segment for each treatment group, data are expressed as mean ± S.E. (the length is 360 mm, n ¼ 8 per group, *Po0.05, **Po0.01.). (n) Quantification of the apoptotic bodies (the length is 360 mm, n ¼ 8 per group, *Po0.05, **Po0.01)
Otoprotection by G9a/GLP inhibition H Yu et al that the organs of Corti pre-conditioned with BIX01294 showed higher levels of visible TMRM fluorescence than the neomycin-only treated tissues (Figures 7a-c) .
We next examined the expression of cleaved caspase-3, which is a late effector of apoptosis and a major mediator of aminoglycoside-induced apoptosis in auditory hair cells. 19 We found that BIX01294 pre-treated samples showed much lower expression of cleaved caspase-3 than the neomycinonly control group in both immunofluorescence and western blot analyses (Figures 7d-f) . Together with the TMRM results, this indicated that pre-treatment of BIX01294 may suppress the apoptotic cascade induced by the aminoglycosides.
BIX01294 protects hair cells from aminoglycosideinduced cell damage in vivo. To test whether BIX01294 could prevent hair cell loss induced by aminoglycoside in vivo, we performed a self-controlled in vivo experiment in a mouse model of hair cell damage (Supplementary Figure S1) . Scanning electron microscope (SEM) was used to examine the surface morphology of the organs of Corti following the physiological analysis of the hearing thresholds by ABR to assess hair cell functions. In the neomycin-only treated cochleae, the stereocilia fusions were primarily observed in the apical segment, while the stereocilia bundle loss was apparent in the middle and basal segments, accompanying a massive loss of outer hair cells (Figures 8a-f) . The contralateral cochleae pre-treated with BIX01294 were slightly less damaged, with more surviving stereocilia bundles in the basal segment (Figures 8g-l) . The number of surviving hair cells, as quantified by Myosin-7-positive cells, was significantly higher in the BIX01294 pre-treated ears than in the neomycin-only ears (P-value ¼ 0.011, P-value o0.001, and P-value o0.001 in the apical, middle, and basal sections, respectively) (Figure 8m ). In addition, the 'transitional' zone in the BIX01294 pre-treated ears was much closer to the basal border within the middle segment (Figure 8n) . Within this region, we observed some remaining apoptotic nuclei with marginated and condensed chromatin, as shown by Hoechst 33342 staining (Figures 8h, i, and l) . Concordant with previous findings, the neomycin treatment caused a significant ABR-threshold shift, whereas BIX01294 pre-conditioning ameliorated this threshold shift (Supplementary Figure S2) . Quantitative analysis of the ABR showed that the amelioration was at least 15 dB at both 8000 and 16 000 Hz (P-value ¼ 0.0011 and P-value o0.001, respectively) (Figure 8o ). 
Discussion
Histone modifications in various forms constitute a major force in the epigenetic regulation of gene expression. Coordinated activities of histone modification enzymes have been proposed to create a 'histone code' that controls transcription and other genome functions, such as replication and DNA repair. [20] [21] [22] In particular, histone methylation and demethylation are associated with transcription regulation, genome integrity, and epigenetic inheritance. 23 As one of the most abundant and dynamic histone modifications, H3K9me2 patterns vary greatly during development and in disease pathogenesis. 24 It has been shown that H3K9me2 levels increase during ES-cell differentiation while decreasing before the reprogramming of somatic cells to iPS, [25] [26] [27] indicating its role in cell differentiation or cell fate determination. Moreover, the enrichment of H3K9me2 is associated with various types of perpetuating malignancy in cancer cells, 28, 29 as well as in hypoxic stress, which may function through various pathways. 30, 31 In the present study, we first examined the H3K9me2 level upon aminoglycoside-induced hair cell damage in cultured cochlear explants. We found that neomycin treatment induced a rapid increase of the H3K9me2 level in the organ of Corti before detectable apoptosis. The enrichment of H3K9me2 disappeared after 24 h of prolonged neomycin treatment, largely due to severe loss of hair cells. Thus we hypothesised that the increased H3K9me2 level may contribute to the onset of active cell death in hair cell injury. Previous studies also found the enrichment of H3K9me2 or G9a in different cancer cells following hypoxia, although the chronological order of the apoptosis and the H3K9me2 upregulation has not been established. 32, 33 We then asked whether blocking this increase of H3K9me2 level can suppress the onset of the apoptotic programme induced by aminoglycoside and prevent the consequent hair cell death. Indeed, we found that inhibition of G9a/GLP by pharmacological inhibitors BIX01294 or UNC0638 blocks the rapid increase of H3K9me2 and prevents hair cell loss induced by neomycin. Peltonen et al. 34 confirmed that certain cancer cells are susceptible to apoptosis, which may be associated with the regulation of p53. Substantial evidence suggests that the interference of H3K9me2, which is involved in the regulation of gene expression, may influence the susceptibility or tolerance of the cells to stress. Therefore, it is possible that G9a/GLP inhibition may lead to the suppression of specific gene expression changes resulted from the histone We have shown that G9a/GLP inhibition by BIX01294 or UNC0638 are effective in terms of preventing hair cell damage induced by aminoglycosides both ex vivo and in vivo. However, the mechanisms of otoprotection by BIX01294 or UNC0638 remain undetermined. It was believed that apoptotic cell death, instead of necrosis, is the primary cause of hair cell death induced by aminoglycosides. 35, 36 Measuring TUNEL-positive nuclei and the activated caspase-3 labelling, Taylor et al. 37 demonstrated that most hair cells die via a classical apoptotic pathway, and we have shown here that the caspase-dependent pathway was suppressed by BIX01294 pre-treatment. Besides caspase-3, the collapse of membrane potential of the mitochondria is another signal of early apoptosis event. 38 Our TMRM staining indicated that BIX01294 is able to prevent the neomycin-induced disruption of the mitochondrial membrane potential and may lead to new insights into the mechanism of otoprotection. The detailed effect of G9a/GLP inhibition and consequent H3K9me2 reduction on mitochondrial function remains unknown.
In summary, our findings revealed a novel epigenetic mechanism underlying hair cell injury. Inhibition of H3K9me2 may disrupt the apoptotic cell death programme induced by aminoglycosides and thus prevents hair cell loss. Such findings provide novel scientific insights into hair cell damage and may contribute to the development of hair cellprotection therapies. A more complete picture of signalling pathways and molecular mechanisms underlying this otoprotection should be elucidated in future studies.
Materials and Methods
In vitro studies Animal care: Animal care and use were in accordance with the 'Guiding Directive for Humane treatment of Laboratory Animals'. The procedure was approved by the Chinese Science Academy Committee on Care and Use of Animals and performed using accepted veterinary standards. Post-natal day-2 transgenic mice containing the Math1-GFP transgene were used in the in vitro experiments. The mouse line was a generous gift from M. Charles Liberman, as previously described. 39 Tissue culture and compound administration: Dissection and culture of the mouse cochlear explant were performed as previously described. 40 The tissues were Otoprotection by G9a/GLP inhibition H Yu et al cultured on poly-L-lysine-treated (Sigma-Aldrich, St. Louis, MO, USA) cover slides filled with 30 ml of serum-free medium, which consists of DMEM/F12 basal medium supplemented with N2 and B27 solutions (Invitrogen, Carlsbad, CA, USA). The cover slides were placed in a 35-mm dish. To obtain a flat basilar membrane surface, the Reissner's membrane, spiral ligament, and stria vascular were carefully removed. After the tissues were attached to the slides, 1.5 ml of medium was added to the petri dish. Half of the medium was replenished every other day. After the tissues were attached to the slides, they were incubated with the medium containing specific G9a/GLP inhibitors, 2 mM BIX01294 or 2 mM UNC0638 (Sigma-Aldrich), neomycin (1 mM) or a combination of both for designated times, as shown in Supplementary Tables S2 and S3 .
Quantification of the surviving hair cells: To quantify the viable hair cells, the entire cochlea was divided into six segments of equal length, which were called segment 1, 2, 3, 4, 5, and 6 from apex to the base. The hair cells marked with Math1-GFP in the central field of view (360 mm in each segment) were counted. Data are presented as means±S.E.M. ANOVA, the SNK-q test, or Student's t-test were performed to analyse the compound effects. Differences between groups were considered statistically significant when Po0.05.
Apoptotic labelling: Apoptotic cells were detected by the presence of nuclear condensation or fragmentation by using DAPI staining (Sigma-Aldrich), which was performed as previously described. 41 This was also confirmed by TUNEL labelling (Fluorescein In situ Cell death detection kit, Millipore, Bedford, MA, USA) according to the manufacturer's instruction. Quantification of the apoptotic cells in the cochlea was performed in the same way as described above.
GTTR and FM1-43FX uptake: FM1-43 can enter hair cells as previously described. 42, 43 To measure aminoglycoside uptake, the cochlear organs (neo group and pre-treatment group) were cultured for 24 h as described above. After rinsing with PBS, they were incubated with the same serum-free medium containing GTTR (10 mM) for 30 min or FM1-43FX (Molecular Probes, Eugene, OR, USA) for 3 min. After incubation, the cochlea was fixed for analysis using fluorescent microscopy.
Live-cell Imaging of mitochondrial membrane permeability: The cochlear organs (neo group and pre-treatment group) were cultured and incubated in serum-free medium containing neomycin (1 mM) for 30 min, followed by serum-free medium containing TMRM (25 nM) for 30 min. The tissues were then washed with PBS before imaging analysis.
Immunohistochemistry: Samples were fixed in 4% paraformaldehyde in PBS for 2 h at room temperature, followed by rinsing three times in PBS. The tissues were then permeabilized in 0.2% Triton X-100 in PBS for 30 min at room temperature, blocked with 10% donkey serum in PBS for 1 h at 37 1C, and then incubated with the primary antibody (diluted in blocking solution) at 4 1C for 48 h. After washing Western blot analysis. For western blot analysis, total protein was isolated from each of the 12 specimens using the AllPrep DNA/RNA/Protein Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. The protein concentrations were determined using a BCA protein kit (Beyotime, Jiangsu, China). In all, 50 mg of the samples from each group were separated by 12% SDS-PAGE. After electrophorsis, the proteins were transferred to PVDF membranes (Millipore). The membranes were blocked with 5% non-fat dried milk in TBST for 1 h at room temperature. After washing, the primary antibodies, including cleaved caspaspe-3 antibody (dilution 1 : 1000), anti-H3K9me2 antibody (dilution 1 : 1000), b-actin antibody (Cell Signaling Technology, Beverly, MA, USA, rabbit polyclonal, dilution 1 : 1000), and anti-histone H3 antibody (Cell Signaling Technology, rabbit polyclonal, dilution 1 : 1000), were added into the blocking buffer overnight at 4 1C. After three times rinsing (10 min each) with TBST, the membranes were incubated with the blocking buffer containing the HRP-conjugated secondary antibody at a concentration of 1 : 5000 (Supersignal West, Pierce, Rockford, IL, USA) for 1 h at room temperature. The immunoreactive bands were visualised using an ECL kit (Pierce). To quantify the relative levels of the protein, images of specific protein bands were assessed by the grey-degree numerical value.
In vivo studies Experimental protocol: Wild-type C57BL/6 mice were used for the in vivo studies. All animal studies were in accordance with the 'Guiding Directive for Humane treatment of Laboratory Animals. As shown in Supplementary Table S4 , we applied a retro-auricular surgical approach in 5-day-old mice following anaesthesia. To evaluate the otoprotection of G9a/GLP inhibition, the left ears were pre-treated with BIX01294 while the right ears were left untreated as the self-control. A piece of gelfoam (1 mm 3 ) soaked with BIX01294 (10 mM, 2 ml) was positioned onto the round window niche through the small hole in the bulla, resulting in an approximate applied dose of 25 mg of the drug in each pre-treated ear. The inferior skin incision was then closed with four silk sutures. Two days after administration of BIX01294, neomycin was injected subcutaneously once a day for 4 consecutive days. The neomycin was dissolved in saline at a concentration of 20 mg/ml so that a final dose of 200 mg of neomycin/kg of body weight was obtained by injecting 0.01 ml/g of body weight. Dosing of the neomycin was adjusted according to the accurate weight of the animals each day. Two weeks after exposure to neomycin, the hearing threshold was evaluated by ABR measurement.
ABR:
The ABR analysis was performed in anaesthetised (100 mg/kg ketamine and 25 mg/kg xylazine sodium, i.p.) mice to measure the hearing threshold 2 weeks after the administration of neomycin. The hearing threshold was assessed at four frequencies (8, 16, 24 , and 32 kHz) in a TDT system 3 (Tucker Davies Technologies, Gainesville, FL, USA). The traditional three electrodes (stimulus, reference, and grounding electrodes) were inserted subcutaneously at the vertex cranial, homolateral mastoid process, and nasal root, respectively. To prevent the influence from the other ear, the source microphone was positioned directly inside the external auditory canal during the sound acquisition. The threshold response was defined as the lowest response that could demonstrate a reproducible waveform. If there was ambiguity about the results, the ABR would be repeated the following day. The parameters of the evoked responses and acquired signal were as follows: duration of toneburst, 5 ms; rise-fall time, 0.5 ms; stimulus frequency, 21.37/s; stacking fold (superposition times), 500-1000; magnification, 20; bandpass, 0.3-3 kHz; sound intensity variation, 5 dB; amplitude of sound pressure level (SPL), 20-95 dB.
Scanning electron microscopy: The cochlea was perfused immediately with 4% paraformaldehyde after the mouse was anaesthetised. The tissues were then immersed in 2.5% glutaraldehyde for SEM. The SEM samples were post-fixed in 1% phosphate-buffered OsO4, dehydrated in a graded ethanol series, dried and mounted on to an aluminium sheet, and sprayed with gold-palladium. SEM was performed using a Philips XL-30 (Eindhoven, the Netherlands) SEM apparatus.
Immunohistochemistry: Immunohistochemistry was performed similarly as described above. Hair cells were marked with polyclonal anti-myosin 7a (Proteus Biosciences, Ramona, CA, USA). The apoptotic bodies were detected by Hoechst 33342 (Sigma-Aldrich) to identify the condensed or fragmented nuclei.
Statistics:
The results were presented as means ± S.E.M. Student's t-test was performed to determine statistical significance. The results were considered significant when Po0.05 between the groups.
